Group Leader
Dr. Rui Wang-Sattler
“We aim to improve personalized healthcare by integrating OMICs data using statistical, bioinformatical, and machine learning approaches.”
Research
Rui works in the field of metabolic diseases (e.g., type 2 diabetes and cardiovascular diseases). She employs statistical, bioinformatical, and machine learning approaches to integrate metabolomics, transcriptomics, epigenomics, and genomics data in order to identify candidate biomarkers and drug targets, with the final goal to translate our discoveries into clinical practice.
Academic Journey
Rui studied physics and received her diploma from Heidelberg University. For doctoral and postdoctoral research, she worked on population genetics and immunity in the fight against malaria at the European Molecular Biology Laboratory (EMBL). Since 2007, her research focusses on metabolomics studies at the Helmholtz Munich. Rui aims to improve personalized healthcare by integrating OMICs data using machine learning approaches and to train the next generation of researchers.
Skills
Metabolomics OMICs data integration Machine Learning Metabolic Diseases Pharmaometabolomics
Professional Background
2022 Group Leader ITG Group Helmholtz Munich, Germany
Group Leader AME/EPI Helmholtz Munich Germany
Senior Scientist EPI Helmholtz Munich Germany
Postdoctoral Scientist Kafatos & Steinmetz labs EMBL Heidelberg Germany
PhD Kafatos lab EMBL Heidelberg Germany
Study of Physics Heidelberg University Germany
Honors and Awards
- 2010: Paula and Richard von Hertwig Award for Interdisciplinary Cooperation
- 2018: "Verein der Freunde und Förderer" of the Helmholtz Zentrum München (VdFF). VdFF Prize award for Interdisciplinary Collaboration 2016 – 2017
